CT scans reveal drug balloon effects on heart arteries
NCT ID NCT07373145
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is observing 165 adults with coronary artery disease who are getting a drug-coated balloon procedure. Researchers will use CT scans before and after the procedure to measure changes in blood flow and plaque buildup. The goal is to learn how the balloon affects the arteries and how those changes relate to patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- drug-coated balloon
- What this could lead to
- If successful, this could help doctors better understand how drug-coated balloons affect heart arteries, potentially leading to improved treatment strategies for coronary artery disease.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test if the balloon works better than other options. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
RECRUITINGSeoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan replace invasive heart imaging before bypass surgery?
- Epilepsy drug may protect organs during heart surgery — trial tests the idea
- A simple eye mask might protect sleep and calm confusion after heart surgery
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program